Page last updated: 2024-10-30

lobenzarit and Diabetes Insipidus

lobenzarit has been researched along with Diabetes Insipidus in 1 studies

lobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpd

Diabetes Insipidus: A disease that is characterized by frequent urination, excretion of large amounts of dilute URINE, and excessive THIRST. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as ADH or VASOPRESSIN) secreted by the NEUROHYPOPHYSIS, impaired KIDNEY response to ADH, and impaired hypothalamic regulation of thirst.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishinarita, S1
Hayakawa, J1
Suzuki, R1
Hayama, T1
Hiranuma, M1
Sawada, S1
Horie, T1

Other Studies

1 other study available for lobenzarit and Diabetes Insipidus

ArticleYear
[Lobenzarit disodium (CCA)--induced diabetes insipidus in a patient with rheumatoid arthritis].
    Ryumachi. [Rheumatism], 1992, Volume: 32, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diabetes Insipidus; Female; H

1992